 Rhabdoid Tumor
"Rhabdoid Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. (From Holland et al., Cancer Medicine, 3d ed, p2210)
| Descriptor ID |
D018335
|
| MeSH Number(s) |
C04.557.435.710
|
| Concept/Terms |
Rhabdoid Tumor- Rhabdoid Tumor
- Rhabdoid Tumors
- Tumor, Rhabdoid
- Tumors, Rhabdoid
|
Below are MeSH descriptors whose meaning is more general than "Rhabdoid Tumor".
Below are MeSH descriptors whose meaning is more specific than "Rhabdoid Tumor".
This graph shows the total number of publications written about "Rhabdoid Tumor" by people in this website by year, and whether "Rhabdoid Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2007 | 3 | 0 | 3 | | 2008 | 2 | 1 | 3 | | 2009 | 4 | 0 | 4 | | 2010 | 2 | 0 | 2 | | 2011 | 3 | 0 | 3 | | 2012 | 2 | 0 | 2 | | 2013 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2018 | 3 | 0 | 3 | | 2019 | 3 | 0 | 3 | | 2020 | 2 | 0 | 2 | | 2022 | 3 | 0 | 3 | | 2023 | 5 | 0 | 5 | | 2024 | 1 | 0 | 1 | | 2025 | 5 | 0 | 5 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Rhabdoid Tumor" by people in Profiles.
-
Rinehardt HN, Tracy ET, Paredes A, Beckhorn C, Leraas HJ, Fusco J, McKay KG, Kontchou NT, Kastenberg ZJ, Hoyt DW, Roach J, Myers EK, Cost NG, Mullapudi B, Marchese CR, Jensen AR, Lautz TB, Carter M, Dasgupta R, Lundstedt J, Brungardt JG, Talbot L, Davidoff AM, Murphy AJ, Aldrink JH, Mansfield S, Piche N, Le-Nguyen A, Lal DR, Craig BT, Schuh JM, Cromeens BP, Mannava S, Castle S, Lopez A, Mello K, Short J, Petroze RT, Rajavel S, Thompson GR, Mattei P, Rothstein DH, Fialkowski E, Fowler K, Martchenke N, Rich BS, Glick RD, Brown EG, Doyle K, Abril P, Seemann N, Davidson J, Wilson CA, Le HD, Joshi D, Stellon M, Ahmed T, Dimmer A, Ehrlich PF, Hammoud M, Williams K, Grant CN, Gorgy M, Polites SF, Debertin J, Cameron DB, Stetson A, Kim ES, Lee WG, Barkhordar A, Austin M, Coakley BA, Kahan A, Murphy JT, Pitonak M, Boehmer C, Malek MM. Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative. Pediatr Blood Cancer. 2026 Jun; 73(6):e70296.
-
Blanco-Carmona E, Paassen I, He J, DeMartino J, Büllesbach A, Anderson N, Buhl JL, Federico A, Mauermann M, Brok M, Straathof K, Behjati S, Vibhakar R, Donson AM, Foreman NK, Shaw M, Frühwald MC, Korshunov A, Hasselblatt M, Thomas C, Franke N, Kranendonk MEG, Hoving EW, Jäger N, Johann PD, Pfister SM, Filbin MG, Kool M, Drost J. A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories. Neuro Oncol. 2025 Dec 01; 27(12):3260-3275.
-
Alimova I, Wang D, DeSisto J, Danis E, Lakshmanachetty S, Prince E, Murdock G, Pierce A, Donson A, Balakrishnan I, Serkova N, Lin H, Foreman NK, Dahl N, Venkataraman S, Vibhakar R. SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRT. Mol Cancer Res. 2025 06 03; 23(6):515-529.
-
Hoang TT, Ho TD, Subramanian PS. Pediatric isolated oculomotor nerve palsy induced by peduncular atypical teratoid/rhabdoid tumor: case report and literature review. J AAPOS. 2025 Apr; 29(2):104173.
-
Pauck D, Picard D, Maue M, Taban K, Marquardt V, Blümel L, Bartl J, Qin N, Kubon N, Schöndorf D, Meyer FD, Theruvath J, Mitra S, Hasselblatt M, Frühwald MC, Reifenberger G, Remke M. An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT). Pharmacol Res. 2025 Mar; 213:107660.
-
Perotti D, O'Sullivan MJ, Walz AL, Davick J, Al-Saadi R, Benedetti DJ, Brzezinski J, Ciceri S, Cost NG, Dome JS, Drost J, Evageliou N, Furtwängler R, Graf N, Maschietto M, Mullen EA, Murphy AJ, Ortiz MV, van der Beek JN, Verschuur A, Wegert J, Williams R, Spreafico F, Geller JI, van den Heuvel-Eibrink MM, Hong AL. Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. Nat Rev Urol. 2025 08; 22(8):526-543.
-
Nguyen LT, Hains AE, Aziz-Zanjani MO, Dalsass M, Farooqee SBUD, Lu Y, Jackson PK, Van Rechem C. Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs. J Biol Chem. 2024 12; 300(12):107988.
-
Geller JI, Hong AL, Vallance KL, Evageliou N, Aldrink JH, Cost NG, Treece AL, Renfro LA, Mullen EA. Children's Oncology Group's 2023 blueprint for research: Renal tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30586.
-
Johann PD, Altendorf L, Efremova EM, Holsten T, Steinbügl M, Nemes K, Eckhardt A, Kresbach C, Bockmayr M, Koch A, Haberler C, Antonelli M, DeSisto J, Schuhmann MU, Hauser P, Siebert R, Bens S, Kool M, Green AL, Hasselblatt M, Frühwald MC, Schüller U. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics. Acta Neuropathol. 2023 09; 146(3):527-541.
-
Mestnik S, Wilson S, Huang A, Sato M. Prolonged remission achieved with maintenance intraventricular chemotherapy in young patient with recurrent atypical teratoid rhabdoid tumor. Pediatr Blood Cancer. 2023 06; 70(6):e30225.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|